Abstract:Antioxidant therapies are of interest in the prevention and management of ocular disorders such as cataracts. Although an active area of interest, topical therapy with antioxidants for the treatment of cataracts is complicated by multiple ocular anatomical barriers, product stability, and solubility. Entrapment and delivery of antioxidants with poly(lactic-co-glycolic acid) nanoparticles is a possible solution to these challenges, however, little is known regarding their effects in vitro or in vivo. Our first aim was to investigate the impact of blank and lutein loaded PLGA nanoparticles on viability and development of reactive oxygen species in lens epithelial cells in vitro. Photo-oxidative stress was induced by ultraviolet light exposure with cell viability and reactive oxygen species monitored. Next, an in vivo, selenite model was utilized to induce cataract formation in rodents. Eyes were treated topically with both free lutein and lutein loaded nanoparticles (LNP) at varying concentrations. Eyes were monitored for the development of anterior segment changes and cataract formation. The ability of nanodelivered lutein to reach the anterior segment of the eye was evaluated by liquid chromatography coupled to mass spectrometry of aqueous humor samples and liquid chromatography coupled to tandem mass spectrometry (targeted LC-MS/MS) of lenses. LNP had a minimal impact on the viability of lens epithelial cells during the short exposure timeframe (24 h) and at concentrations < 0.2 μg LNP/μl. A significant reduction in the development of reactive oxygen species was also noted. Animals treated with LNPs at an equivalent lutein concentration of 1,278 μg /mL showed the greatest reduction in cataract scores. Lutein delivery to the anterior segment was confirmed through evaluation of aqueous humor and lens sample evaluation. Topical treatment was not associated with the development of secondary keratitis or anterior uveitis when applied once daily for one week. LNPs may be an effective in the treatment of cataracts.

&Lt;p>liquid Antisolvent Precipitation: an Effective Method for Ocular Targeting of Lutein Esters</p>

Liquid antisolvent precipitation: an effective method for ocular targeting of lutein esters

Physicochemical Properties and Bioavailability of Lutein Microencapsulation(LM)

Optimization of preparation, characterization, and dissolution characteristics of lutein ester nanoparticles by anti-solvent method

Hyaluronic Acid Modified Lutein Nanoparticles for Effective Application in Eye Drops: Development, Characterization, and Evaluation

Utilization of Biopolymer-Based Lutein Emulsion as an Effective Delivery System to Improve Lutein Bioavailability in Neonatal Rats

The impact of lutein-loaded poly(lactic-co-glycolic acid) nanoparticles following topical application: An in vitro and in vivo study

Preparation, characterization, and properties of lutein block polyethylene glycol copolymer loading with lutein nanoparticles

Comparative study of the properties of lutein nanoliposomes coated with chitosan/(-)-epigallocatechin- 3-gallate (EGCG) complexes

Stabilisation of Lutein and Lutein Esters with Polyoxyethylene Sorbitan Monooleate, Medium-Chain Triglyceride Oil and Lecithin

Zein/soluble soybean polysaccharide composite nanoparticles for encapsulation and oral delivery of lutein

Solid lipid nanoparticles of lutein with improved dissolution behavior and oral absorption

Cocrystal of Lutein with Improved Stability and Bioavailability

Poly (d, l-lactide-co-glycolide)-phospholipid nanocarrier for efficient delivery of macular pigment lutein: absorption pharmacokinetics in mice and antiproliferative effect in Hep G2 cells

Physicochemical Properties Of Lutein-Loaded Microcapsules And Their Uptake Via Caco-2 Monolayers

Nanostructured Lipid Carriers (nlcs) Stabilized by Natural or Synthetic Emulsifiers for Lutein Delivery: Improved Physicochemical Stability, Antioxidant Activity, and Bioaccessibility

Developing biopolymer-stabilized emulsions for improved stability and bioaccessibility of lutein

Improvements of solubility and bioavailability of lutein through grafting with hydrophilic polyacrylic acid

Preparation of Lutein Nanoparticles by Glycosylation of Saccharides and Casein for Protecting Retinal Pigment Epithelial Cells

Utilization of -lactoglobulin- (-)-Epigallocatechin-3-gallate(EGCG) composite colloidal nanoparticles as stabilizers for lutein pickering emulsion

Sodium Caseinate and Acetylated Mung Bean Starch for the Encapsulation of Lutein: Enhanced Solubility and Stability of Lutein

&Lt;p&gt;liquid Antisolvent Precipitation: an Effective Method for Ocular Targeting of Lutein Esters&lt;/p&gt;